Value of bone resorption markers to predict skeletal related events and response to bisphosphonate therapy in patients with bone metastases : A prspective randomized study / Nermine Shawki Kamal ; Supervised Wafaa Elmetenawy , Hamdy Abdelazim , Emad Hamada
Material type:
TextLanguage: eng Publication details: Cairo : Nermine Shawki Kamal , 2009Description: 215P. : charts , facsimiles ; 25cmOther title: - قيمة دلالات اورام تأكل العظام لمعرفة تأثيرها على العظام ومدى استجابتها البيسفوسفونات على علاج مرضى الاورام السرطانية المنتشرة بالعظم [Added title page title]
- Issued also as CD
| Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
|---|---|---|---|---|---|---|---|
Thesis
|
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.23.Ph.D.2009.Ne.V (Browse shelf(Opens below)) | Not for loan | 01010110052582000 | ||
CD - Rom
|
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.23.Ph.D.2009.Ne.V (Browse shelf(Opens below)) | 52582.CD | Not for loan | 01020110052582000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology (Clinical)
The prospective analysis of urinary N - telopeptides collagen break down products type I (NTX) in patients with metastatic bone disease revealed a positive relation between NTX level and risk of Sketal related events (SREs). Normalization of NTX level at 3 months decreases the rate of serious types of SREs (pathological fractures and cord compression) . Zoledronic acid decreases the rate of one or more SREs by four times in patients with elevated NTX levels compared to no Zoledronic acid
Issued also as CD
There are no comments on this title.
Click on an image to view it in the image viewer